These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14979908)

  • 61. Beta-catenin/T-cell factor-mediated transcription is modulated by cell density in human bronchial epithelial cells.
    Steel MD; Puddicombe SM; Hamilton LM; Powell RM; Holloway JW; Holgate ST; Davies DE; Collins JE
    Int J Biochem Cell Biol; 2005 Jun; 37(6):1281-95. PubMed ID: 15778091
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer.
    Biswas DK; Iglehart JD
    J Cell Physiol; 2006 Dec; 209(3):645-52. PubMed ID: 17001676
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Epidermal growth factor promotes epidermal growth factor receptor nuclear accumulation by a pathway dependent on cytoskeleton integrity in human breast cancer cells.
    Cortes-Reynosa P; Robledo T; Salazar EP
    Arch Med Res; 2009 Jul; 40(5):331-8. PubMed ID: 19766894
    [TBL] [Abstract][Full Text] [Related]  

  • 64. TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells.
    Gschwind A; Hart S; Fischer OM; Ullrich A
    EMBO J; 2003 May; 22(10):2411-21. PubMed ID: 12743035
    [TBL] [Abstract][Full Text] [Related]  

  • 65. ErbBs in mammary development.
    Stern DF
    Exp Cell Res; 2003 Mar; 284(1):89-98. PubMed ID: 12648468
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Wnt1 and Wnt5a induce cyclin D1 expression through ErbB1 transactivation in HC11 mammary epithelial cells.
    Civenni G; Holbro T; Hynes NE
    EMBO Rep; 2003 Feb; 4(2):166-71. PubMed ID: 12612606
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Identification of a Wnt/Dvl/beta-Catenin --> Pitx2 pathway mediating cell-type-specific proliferation during development.
    Kioussi C; Briata P; Baek SH; Rose DW; Hamblet NS; Herman T; Ohgi KA; Lin C; Gleiberman A; Wang J; Brault V; Ruiz-Lozano P; Nguyen HD; Kemler R; Glass CK; Wynshaw-Boris A; Rosenfeld MG
    Cell; 2002 Nov; 111(5):673-85. PubMed ID: 12464179
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors.
    Rosner A; Miyoshi K; Landesman-Bollag E; Xu X; Seldin DC; Moser AR; MacLeod CL; Shyamala G; Gillgrass AE; Cardiff RD
    Am J Pathol; 2002 Sep; 161(3):1087-97. PubMed ID: 12213737
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors.
    Miyoshi K; Rosner A; Nozawa M; Byrd C; Morgan F; Landesman-Bollag E; Xu X; Seldin DC; Schmidt EV; Taketo MM; Robinson GW; Cardiff RD; Hennighausen L
    Oncogene; 2002 Aug; 21(36):5548-56. PubMed ID: 12165853
    [TBL] [Abstract][Full Text] [Related]  

  • 70. ErbB-beta-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas.
    Schroeder JA; Adriance MC; McConnell EJ; Thompson MC; Pockaj B; Gendler SJ
    J Biol Chem; 2002 Jun; 277(25):22692-8. PubMed ID: 11950845
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours.
    Wong SC; Lo SF; Lee KC; Yam JW; Chan JK; Wendy Hsiao WL
    J Pathol; 2002 Feb; 196(2):145-53. PubMed ID: 11793365
    [TBL] [Abstract][Full Text] [Related]  

  • 72. WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type.
    Ugolini F; Charafe-Jauffret E; Bardou VJ; Geneix J; Adélaïde J; Labat-Moleur F; Penault-Llorca F; Longy M; Jacquemier J; Birnbaum D; Pébusque MJ
    Oncogene; 2001 Sep; 20(41):5810-7. PubMed ID: 11593386
    [TBL] [Abstract][Full Text] [Related]  

  • 73. beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland.
    Michaelson JS; Leder P
    Oncogene; 2001 Aug; 20(37):5093-9. PubMed ID: 11526497
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Wnt signaling and mammary tumorigenesis.
    Smalley MJ; Dale TC
    J Mammary Gland Biol Neoplasia; 2001 Jan; 6(1):37-52. PubMed ID: 11467451
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Specific protection against breast cancers by cyclin D1 ablation.
    Yu Q; Geng Y; Sicinski P
    Nature; 2001 Jun; 411(6841):1017-21. PubMed ID: 11429595
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Hedgehog and Wnt signalling pathways in cancer.
    Taipale J; Beachy PA
    Nature; 2001 May; 411(6835):349-54. PubMed ID: 11357142
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Delta N89 beta-catenin induces precocious development, differentiation, and neoplasia in mammary gland.
    Imbert A; Eelkema R; Jordan S; Feiner H; Cowin P
    J Cell Biol; 2001 Apr; 153(3):555-68. PubMed ID: 11331306
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Untangling the ErbB signalling network.
    Yarden Y; Sliwkowski MX
    Nat Rev Mol Cell Biol; 2001 Feb; 2(2):127-37. PubMed ID: 11252954
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Wnt signaling and cancer.
    Polakis P
    Genes Dev; 2000 Aug; 14(15):1837-51. PubMed ID: 10921899
    [No Abstract]   [Full Text] [Related]  

  • 80. Cooperative induction of mammary tumorigenesis by TGFalpha and Wnts.
    Schroeder JA; Troyer KL; Lee DC
    Oncogene; 2000 Jun; 19(28):3193-9. PubMed ID: 10918574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.